Miki Nakajima
Kanazawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 158 publications
Chromobox 4 interacts with pregnane X receptor to repress CYP3A4 expression through polycomb repressive complex 1/2-mediated epigenetic regulation.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: March 30, 2026
CYP1A2 and ADH1C contribute to abacavir aldehyde intermediate formation in the human liver.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: March 23, 2026
Nucleolar and coiled-body phosphoprotein 1 enhances the induction of CYP3A4 by promoting nuclear translocation of pregnane X receptor.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: March 20, 2026
Arylacetamide deacetylase plays a protective role against amodiaquine-induced liver injury by suppressing ferroptosis.
Journal: Chemico-biological interactions
Published: March 10, 2026
Arylacetamide deacetylase attenuates hepatic lipid accumulation under ER stress conditions by regulating iron-dependent oxidative stress.
Journal: Toxicology and applied pharmacology
Published: February 11, 2026
Regulatory impact of G-quadruplexes in the human carboxylesterase 2 gene on drug and lipid metabolism.
Journal: Drug metabolism and pharmacokinetics
Published: January 05, 2026
Impact of renal hypoxia on OAT1 expression and adefovir-induced cytotoxicity in human 3D-RPTEC spheroids.
Journal: Toxicology and applied pharmacology
Published: December 22, 2025
Impact of renal hypoxia on OAT1 expression and adefovir-induced cytotoxicity in human 3D-RPTEC spheroids.
Journal: Toxicology and applied pharmacology
Published: December 22, 2025
Arylacetamide deacetylase deficiency potentiates ketoconazole-induced inhibition of triazolam metabolism in mice.
Journal: Drug metabolism and pharmacokinetics
Published: November 10, 2025
An in vitro approach to predict idiosyncratic drug-induced agranulocytosis using myeloperoxidase-derived reactive metabolites.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: October 21, 2025
Identification of alcohol dehydrogenase (ADH) isoforms catalyzing hydroxyzine oxidation using recombinant human ADH: Serendipitous finding of potent ADH inhibition by organic solvents.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: October 10, 2025
N6-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549 cells.
Journal: Drug metabolism and pharmacokinetics
Published: September 11, 2025
Last Updated: 09/26/2026